Latest Lead News

Orcoda Limited has locked in six new multi-year SaaS contracts with Australian community transport providers following a successful government-backed trial, pushing its annual recurring revenue to approximately $5 million.

Ionic Rare Earths’ UK subsidiary, Ionic Technologies, has won £11 million in government funding to spearhead a pioneering rare earth permanent magnet supply chain for electric vehicles, aiming to reduce UK dependence on Chinese exports and boost domestic EV manufacturing.

DY6 Metals has raised A$4.625 million through a placement to accelerate exploration of its rutile projects in Cameroon, alongside appointing industry veteran Cliff Fitzhenry as CEO to lead the charge.

Macquarie Technology Group’s subsidiary has secured an option to acquire a prime Sydney site for a major new data centre campus, aiming to boost capacity for AI, cloud, and government clients.

Indiana Resources appoints seasoned mining executive Matthew Bowles as Managing Director to spearhead expansion at its Minos Gold Project, while promoting John Fitzgerald to COO amid a strong cash position.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.

InteliCare has launched a three-month trial of its AI-powered platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy with a leading aged care provider.

Mithril Silver and Gold Limited has arranged a placement to raise up to C$11.5 million, aiming to accelerate exploration at its Copalquin project in Mexico’s prolific Sierra Madre Trend.

Diablo Resources has successfully raised $396,000 to fund drilling at its Phoenix Copper Project, targeting promising copper and silver prospects adjacent to the Lisbon Valley Copper Mine.

Almonty Industries has released an updated JORC technical report for its Sangdong Tungsten Mine, affirming Phase I production commencement in late 2025 and outlining plans for a fully permitted Phase II expansion to double throughput.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Ventia has expanded its partnership with NBN Co through a $280 million contract amendment to upgrade fibre infrastructure in the Australian Capital Territory, marking a strategic geographic expansion.